BridgeBio Pharma, Inc. (BIT:1BBIO)

BridgeBio Pharma Statistics

Total Valuation

BIT:1BBIO has a market cap or net worth of EUR 5.54 billion. The enterprise value is 6.72 billion.

Market Cap	5.54B
Enterprise Value	6.72B

Important Dates

The next estimated earnings date is Friday, August 1, 2025.

Earnings Date	Aug 1, 2025
Ex-Dividend Date	n/a

Share Statistics

Current Share Class	189.88M
Shares Outstanding	n/a
Shares Change (YoY)	+11.59%
Shares Change (QoQ)	+0.37%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	146.26M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	47.03
PB Ratio	-3.66
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	-10.87
EV / Sales	59.75
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-14.50

Financial Position

The company has a current ratio of 4.57

Current Ratio	4.57
Quick Ratio	4.31
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	-3.71
Interest Coverage	-5.67

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	-48.27%
Return on Invested Capital (ROIC)	-91.66%
Return on Capital Employed (ROCE)	-91.62%
Revenue Per Employee	161,929
Profits Per Employee	-848,907
Employee Count	730
Asset Turnover	0.15
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

Beta (5Y)	n/a
52-Week Price Change	n/a
50-Day Moving Average	n/a
200-Day Moving Average	n/a
Relative Strength Index (RSI)	n/a
Average Volume (20 Days)	12

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	7.45

Income Statement

In the last 12 months, BIT:1BBIO had revenue of EUR 117.88 million and -618.00 million in losses. Loss per share was -3.27.

Revenue	117.88M
Gross Profit	112.41M
Operating Income	-618.42M
Pretax Income	-625.10M
Net Income	-618.00M
EBITDA	-613.08M
EBIT	-618.42M
Loss Per Share	-3.27

Balance Sheet

The company has 500.16 million in cash and 1.72 billion in debt, giving a net cash position of -1.22 billion.

Cash & Cash Equivalents	500.16M
Total Debt	1.72B
Net Cash	-1.22B
Net Cash Per Share	n/a
Equity (Book Value)	-1.52B
Book Value Per Share	-8.03
Working Capital	502.45M

Cash Flow

In the last 12 months, operating cash flow was -462.99 million and capital expenditures -220,198, giving a free cash flow of -463.21 million.

Operating Cash Flow	-462.99M
Capital Expenditures	-220,198
Free Cash Flow	-463.21M
FCF Per Share	n/a

Margins

Gross Margin	95.35%
Operating Margin	-524.60%
Pretax Margin	-530.27%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

BIT:1BBIO does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-11.59%
Shareholder Yield	n/a
Earnings Yield	-11.15%
FCF Yield	-8.35%

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

BIT:1BBIO has an Altman Z-Score of -5.54. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-5.54
Piotroski F-Score	n/a